| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,343 |
1,194 |
$63K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
68 |
64 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
88 |
85 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
93 |
85 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
51 |
48 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
230 |
198 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
39 |
30 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
38 |
27 |
$2K |
| 90686 |
|
207 |
184 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
13 |
$1K |
| 0002A |
|
14 |
14 |
$589.96 |
| 0071A |
|
12 |
12 |
$505.68 |
| 0001A |
|
12 |
12 |
$505.68 |
| 96127 |
|
30 |
12 |
$438.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32 |
32 |
$412.16 |
| 80061 |
Lipid panel |
12 |
12 |
$74.64 |
| 85018 |
|
32 |
32 |
$74.24 |
| 82947 |
|
12 |
12 |
$39.48 |